Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel and Accru Partners in connection with the acquisitions of Baker Tilly Helsingborg AB, MOORE Allegretto AB and MOORE Ranby AB
Mandate

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Baker Tilly Helsingborg AB, MOORE Allegretto AB and MOORE Ranby AB

September 18, 2025 M&A Employment and Benefits Banking and Finance Commercial Agreements IT, Telecommunications and Outsourcing Data protection and processing of personal data Real Estate and Construction Financial Regulatory Contentious Regulatory

Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Baker Tilly Helsingborg AB, MOORE Allegretto AB and MOORE Ranby AB.

Baker Tilly Helsingborg AB, MOORE Allegretto AB and MOORE Ranby AB are entrepreneur-led, local businesses with expertise in accounting, audit, tax, and advisory services. After the acquisitions, Accru Partners consists of 49 independent firms within the aforementioned business areas.

Vinge’s team consisted of Christina Kokko, Desirée Hagenfeldt, Egil Svensson, Michella Lina Said and Chris Bastholm (M&A), Alice Göransson and Simon Söderholm (Employment), Sofia Haggren (Banking and Finance), Mario Saad (Commercial Agreements), Elis Allmark (IT), Nicklas Thorgerzon (GDPR), Madelene Andersson (Real Property), Jonna Bondemark and Isabelle Asserståhl (Regulatory), Gulestan Ali and Hayaat Ibrahim (Compliance), Emelie Schoning and Jessica Öijer (Transaction Support Coordinator).

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

 Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025